Oculis Holding AG (OCS) Short-term Investments (2023 - 2026)
Quarterly Short-term Investments rose 48.13% to $201.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $201.1 million through Mar 2026, up 48.13% year-over-year, with the annual reading at $164.8 million for FY2025, 103.41% up from the prior year.
Oculis Holding AG's Short-term Investments history spans 4 years, with the latest figure at $201.1 million for Q1 2026.
- Short-term Investments came in at $201.1 million for Q1 2026, up from $164.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $201.1 million in Q1 2026 to a low of $60.1 million in Q4 2023.
- The 4-year median for Short-term Investments is $83.9 million (2024), against an average of $106.2 million.
- Year-over-year, Short-term Investments dropped 6.15% in 2024 and then surged 113.22% in 2025.
- Oculis Holding AG's Short-term Investments stood at $60.1 million in 2023, then surged by 34.74% to $81.0 million in 2024, then soared by 103.41% to $164.8 million in 2025, then increased by 22.05% to $201.1 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Short-term Investments are $201.1 million (Q1 2026), $164.8 million (Q4 2025), and $123.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.09 Mn |
| Dec 31, 2025 | 164.76 Mn |
| Sep 30, 2025 | 123.44 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 135.76 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Sep 30, 2024 | 80.61 Mn |
| Jun 30, 2024 | 81.91 Mn |
| Mar 31, 2024 | 63.67 Mn |
| Dec 31, 2023 | 60.12 Mn |
| Sep 30, 2023 | 85.90 Mn |
| Jun 30, 2023 | 80.16 Mn |